サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452590

中南米のグリオーマ治療：2030年までの市場予測 - 地域別分析 - 疾患別、治療タイプ別、グレード別、エンドユーザー別

South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease, Treatment Type, Grade, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 82 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
中南米のグリオーマ治療：2030年までの市場予測 - 地域別分析 - 疾患別、治療タイプ別、グレード別、エンドユーザー別
出版日: 2024年01月15日
発行: The Insight Partners
ページ情報: 英文 82 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米のグリオーマ治療市場は、2022年の1億1,714万米ドルから2030年には2億2,774万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.7%と推定されます。

新興経済国での機会増加が中南米のグリオーマ治療市場を後押し

ブラジル、ロシア、インド、中国、南アフリカ（BRICS）は、世界で最も急成長している経済圏のひとつです。これらの国々やその他の新興経済諸国の医療分野は、今後数年間で急速に拡大すると予測されています。期待される成長の背景には、顧客需要の変化、ヘルスケアサービスに対する意識の高まり、高齢化人口の継続的な増加があります。脳腫瘍診断薬の世界市場は、ヘルスケア分野の普及に伴い、今後数年間で大きく成長する可能性が高いです。さらに、医療施設に対する政府支出の増加と消費者の購買力が、発展途上国におけるヘルスケア分野の成長に寄与しています。

COVID-19が流行する20年前、南北アメリカ地域の医療サービスのカバー率は、緩やかではあるが改善しました。2000年には65％の人々が健康保険に加入していたのに比べ、2019年には77％の人々が健康保険に加入していました。保健医療に対する政府支出は1.1ポイント拡大し、保健医療従事者数は増加しました。このように、この地域のヘルスケア部門の成長は、グリオーマ治療市場のプレーヤーが事業を拡大する機会を生み出しています。

中南米のグリオーマ治療市場概要

中南米のグリオーマ治療市場は、ブラジル、アルゼンチン、その他南米に区分されます。この地域の市場成長は、脳腫瘍の罹患率の上昇とヘルスケアシステムの新興国市場の開拓が加速していることに起因しています。また、中南米諸国の大学は、様々な非公開会社や公開会社と協力し、脳腫瘍治療に関連する研究を支援しています。神経血管障害に対する意識の高まりも、中南米のグリオーマ治療市場を後押ししています。

ブラジルは、面積と人口で世界第5位の国であり、世界データインフォメーションによると、人口動態の高齢化が最も急速に進んでいます。Globocan 2020の報告書によると、脳腫瘍はブラジルで最も一般的な死因です。2020年にブラジルで新たに報告された脳腫瘍の症例は12,260例で、脳腫瘍と中枢神経系がんによる死亡は10,920例でした。さらに、ブラジルの全年齢における脳腫瘍の5年有病率は、人口10万人当たり15.17人です。アルゼンチンのがん患者数は着実に増加しています。WHOのGlobal Cancer Observatoryが発表したGlobocanレポートによると、アルゼンチンでは2020年に～1,831例の脳腫瘍が新たに診断され、そのうち1,488例が脳腫瘍が原因で死亡したと報告されています。アルゼンチンの全年齢層における脳腫瘍の5年有病率は、人口10万人当たり11.62人でした。

チリ、コロンビア、ペルー、キューバ、ベネズエラ、ボリビアは、中南米におけるグリオーマ治療市場の主要な貢献国です。これらの国々は、マーケットプレースへの新規参入を許可することで、ヘルスケアのインフラを改善しつつあります。さらに、その他中南米の国々は、医療研究活動を改善し、脳腫瘍に対する先進的な治療法を採用することに投資し、関心を寄せています。

中南米のグリオーマ治療市場の収益と2030年までの予測（金額）

中南米のグリオーマ治療市場のセグメンテーション

中南米のグリオーマ治療市場は、疾患、治療タイプ、グレード、エンドユーザー、国に区分されます。

疾患別では、中南米のグリオーマ治療市場は星細胞腫、乏突起星細胞腫、乏突起膠腫にセグメント化されます。2022年の中南米のグリオーマ治療市場で最大のシェアを占めたのは星細胞腫セグメントでした。

治療タイプ別では、中南米のグリオーマ治療市場は手術、化学療法、放射線療法、その他に区分されます。2022年の中南米のグリオーマ治療市場では、手術セグメントが最大のシェアを占めています。

悪性度別では、中南米のグリオーマ治療市場は低悪性度と高悪性度に区分されます。2022年の中南米のグリオーマ治療市場では、高悪性度セグメントが大きなシェアを占めています。

エンドユーザー別では、中南米のグリオーマ治療市場は病院＆クリニックと外来手術センターにセグメント化されます。2022年の中南米のグリオーマ治療市場では、病院＆クリニックセグメントが大きなシェアを占めています。

国別に見ると、中南米のグリオーマ治療市場はブラジル、アルゼンチン、その他南米に区分されます。2022年の中南米のグリオーマ治療市場はブラジルが支配的。

Amgen Inc、Biocon Ltd、F. Hoffmann-La Roche Ltd、Merck &Co Inc、Pfizer Inc、Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltdは、中南米のグリオーマ治療市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米のグリオーマ治療市場：主要産業力学

  • 市場促進要因
    • 南米における脳腫瘍罹患率の高さ
    • 高悪性度グリオーマの有病率の増加
  • 主な市場抑制要因
    • 診断コストの高さ
  • 主な市場機会
    • 新興国におけるヘルスケア分野の進歩
  • 今後の動向
    • グリオーマ治療薬の承認急増
  • インパクト分析

第5章 グリオーマ治療市場：中南米市場分析

  • 中南米のグリオーマ治療市場収益、2022年～2030年

第6章 中南米のグリオーマ治療市場：収益と2030年までの予測 - 疾患別

  • 市場収益シェア（%）、2022年および2030年
  • 星細胞腫
  • 乏突起星細胞腫
  • 乏突起膠腫

第7章 中南米のグリオーマ治療市場：収益と2030年までの予測 - 治療タイプ別

  • 市場収益シェア（%）、2022年および2030年
  • 手術療法
  • 化学療法
  • 放射線療法
  • その他

第8章 中南米のグリオーマ治療市場：収益と2030年までの予測 - グレード別

  • 市場収益シェア（%）、2022年および2030年
  • 低悪性度
  • 高悪性度

第9章 中南米のグリオーマ治療市場：収益と2030年までの予測 - エンドユーザー別

  • 市場収益シェア（%）、2022年および2030年
  • 病院・診療所
  • 外来手術センター

第10章 中南米のグリオーマ治療市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 グリオーマ治療市場：業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • Sun Pharmaceutical Industries Ltd
  • Amgen Inc
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Biocon Ltd

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America Glioma Treatment Market Segmentation
  • Table 2. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 3. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 4. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 5. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 6. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 7. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 8. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 9. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 10. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 11. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
  • Table 12. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
  • Table 13. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 15. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 16. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 17. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 18. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 19. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 20. Organic Developments Done By Companies
  • Table 21. Inorganic Developments Done By Companies
  • Table 22. Glossary of Terms, glioma treatment market

List Of Figures

  • Figure 1. South & Central America Glioma Treatment Market Segmentation, By Country
  • Figure 2. South & Central America Glioma Treatment Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
  • Figure 6. Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • Figure 10. Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
  • Figure 15. Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 22. Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. South & Central America Glioma Treatment Market, By Country, 2022 ($Mn)
  • Figure 25. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 26. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: BMIRE00029271

The South & Central America glioma treatment market is expected to grow from US$ 117.14 million in 2022 to US$ 227.74 million by 2030. It is estimated to grow at a CAGR of 8.7% from 2022 to 2030.

Increasing Opportunities in Emerging Economies Fuels South & Central America Glioma Treatment Market

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The healthcare sectors in these countries, as well as other developing economies, are projected to expand rapidly in the coming years. The expected growth is ascribed to changes in customer demand, an increase in awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer diagnostics market is likely to grow significantly in the coming years with the proliferation of the healthcare sector. Further, increased government spending on healthcare facilities and consumer purchasing power contribute to the growth of the healthcare sector in developing countries.

20 years before the COVID-19 epidemic, health service coverage in the Americas region improved, albeit slowly. Compared to 65% of people in 2000, 77% of people in 2019 had health insurance. Government spending on health expanded by 1.1 percentage points while the number of health personnel increased. Thus, the growing healthcare sector in the region creates opportunities for the glioma treatment market players to expand their business.

South & Central America Glioma Treatment Market Overview

The glioma treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is ascribed to the rising incidence of brain cancer and a spur in developments in healthcare systems. In addition, the universities in Latin American countries are collaborating with various private and public companies to support studies related to brain cancer treatment. The rising awareness about neurovascular disorders is also favoring the glioma treatment market in South & Central America.

Brazil is the fifth largest country in the world by area and population and is experiencing the fastest demographic aging as per the world data.info. As per the Globocan 2020 report, brain cancer is the most common cause of death in Brazil. 12,260 new cases of brain cancer were reported in Brazil in 2020, while brain and CNS cancers led to 10,920 deaths. Further, the 5-year prevalence rate of brain cancer in Brazil for all ages is ~15.17 per 100,000 population. The number of cancer cases in Argentina is increasing at a steady rate. According to the Globocan report published by the Global Cancer Observatory of the WHO, ~1,831 new cases of brain cancer were diagnosed in 2020, of which 1,488 deaths were reported due to brain cancer in Argentina. The 5-years prevalence rate of brain cancer for all age groups was found to be 11.62 per 100,000 population in Argentina.

Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among other the key contributors to the glioma treatment market in South & Central America. These countries are improving their healthcare infrastructure by allowing new market players to enter into the marketplace. In addition, the countries in the Rest of South & Central America are investing and taking an interest in improving their healthcare research activities and adopting advanced therapies for brain cancer.

South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Glioma Treatment Market Segmentation

The South & Central America glioma treatment market is segmented into disease, treatment type, grade, end user, and country.

Based on disease, the South & Central America glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on treatment type, the South & Central America glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. The surgery segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on grade, the South & Central America glioma treatment market is segmented into low grade and high grade. The high grade segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on end user, the South & Central America glioma treatment market is segmented into hospital & clinics and ambulatory surgical center. The hospital & clinics segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on country, the South & Central America glioma treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America glioma treatment market in 2022.

Amgen Inc, Biocon Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Pfizer Inc, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the South & Central America glioma treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Glioma Treatment Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 High Incidence Rate of Brain Cancer in South America
    • 4.1.2 Increase in Prevalence of High-Grade Glioma
  • 4.2 Key Market Restraints
    • 4.2.1 High Cost of Diagnosis
  • 4.3 Key Market Opportunities
    • 4.3.1 Advancements in Healthcare Sector in Emerging Economies
  • 4.4 Future Trends
    • 4.4.1 Surge in Drug Approvals for Glioma Treatment
  • 4.5 Impact Analysis:

5. Glioma Treatment Market - South & Central America Market Analysis

  • 5.1 South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

  • 6.1 Overview
  • 6.2 South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
  • 6.3 Astrocytoma
    • 6.3.1 Overview
    • 6.3.2 Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Oligoastrocytoma
    • 6.4.1 Overview
    • 6.4.2 Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Oligodendroglioma
    • 6.5.1 Overview
    • 6.5.2 Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

  • 7.1 Overview
  • 7.2 South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • 7.3 Surgery
    • 7.3.1 Overview
    • 7.3.2 Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Chemotherapy
    • 7.4.1 Overview
    • 7.4.2 Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Radiation Therapy
    • 7.5.1 Overview
    • 7.5.2 Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

  • 8.1 Overview
  • 8.2 South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
  • 8.3 Low Grade
    • 8.3.1 Overview
    • 8.3.2 Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.2 Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 High Grade
    • 8.4.1 Overview
    • 8.4.2 High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.2 Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospital & Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Glioma Treatment Market - Country Analysis

  • 10.1 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 South & Central America Glioma Treatment Market, by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Brazil: South & Central America Glioma Treatment Market, by Disease
        • 10.1.1.2.3 Brazil: South & Central America Glioma Treatment Market, by Treatment Type
        • 10.1.1.2.4 Brazil: South & Central America Glioma Treatment Market, by Grade
        • 10.1.1.2.4.1 Brazil: South & Central America Glioma Treatment Market, by Low Grade
        • 10.1.1.2.4.2 Brazil: South & Central America Glioma Treatment Market, by High Grade
        • 10.1.1.2.5 Brazil: South & Central America Glioma Treatment Market, by End User
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Argentina: South & Central America Glioma Treatment Market, by Disease
        • 10.1.1.3.3 Argentina: South & Central America Glioma Treatment Market, by Treatment Type
        • 10.1.1.3.4 Argentina: South & Central America Glioma Treatment Market, by Grade
        • 10.1.1.3.4.1 Argentina: South & Central America Glioma Treatment Market, by Low Grade
        • 10.1.1.3.4.2 Argentina: South & Central America Glioma Treatment Market, by High Grade
        • 10.1.1.3.5 Argentina: South & Central America Glioma Treatment Market, by End User
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by Disease
        • 10.1.1.4.3 Rest of South & Central America: South & Central America Glioma Treatment Market, by Treatment Type
        • 10.1.1.4.4 Rest of South & Central America: South & Central America Glioma Treatment Market, by Grade
        • 10.1.1.4.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market, by Low Grade
        • 10.1.1.4.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by High Grade
        • 10.1.1.4.5 Rest of South & Central America: South & Central America Glioma Treatment Market, by End User

11. Glioma Treatment Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 F. Hoffmann-La Roche Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sun Pharmaceutical Industries Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Amgen Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Teva Pharmaceutical Industries Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pfizer Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Biocon Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms